VHL Ligand 8
VHL Ligand 8 is a VHL ligand. VHL Ligand 8 can be used to synthesize ARD-266 , a highly potent and VHL E3 ligase-based androgen receptor (AR) PROTAC degrader. ARD-266 effectively induces degradation of AR protein in AR-positive LNCaP, VCaP, and 22Rv1 prostate cancer cell lines with DC50 values of 0.2-1 nM[1].
Product Specifications
CAS Number
2701565-76-4
UNSPSC
12352005
Hazard Statement
H302, H315, H319, H335
Target
Ligands for E3 Ligase
Type
Reference compound
Related Pathways
PROTAC
Applications
Cancer-programmed cell death
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/vhl-ligand-8.html
Purity
98.04
Solubility
DMSO : 100 mg/mL (ultrasonic)
Smiles
OC(C[C@@H](C1=CC=CC=C1)NC([C@H]2N(C([C@H](C(C)C)C3=CC(C)=NO3)=O)C[C@H](O)C2)=O)=O
Molecular Formula
C23H29N3O6
Molecular Weight
443.49
Precautions
H302, H315, H319, H335
References & Citations
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Isoform
Von Hippel-Lindau (VHL)
Available Sizes
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog
Chromogranin A (PHE5), CF405S conjugate, 0.1mg/mL
CD40 Ligand / CD154 / TRAP1 (Activation Marker of T-Lymphocytes) (CD40LG/2763), CF640R conjugate, 0.1mg/mL
